UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Journal of clinical oncology, 2019-02, Vol.37 (4), p.269-277

2019

Volltextzugriff (PDF)

Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia

Cancer cell, 2015-04, Vol.27 (4), p.502-515

2015

Volltextzugriff (PDF)

Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model

Cancer research (Chicago, Ill.), 2017-04, Vol.77 (8), p.1818-1830

2017

Volltextzugriff (PDF)

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

BMC cancer, 2022-03, Vol.22 (1), p.231-231, Article 231

2022

Volltextzugriff (PDF)

Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma

PloS one, 2012-07, Vol.7 (7), p.e40332

2012

Volltextzugriff (PDF)

BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells

Cancer discovery, 2017-05, Vol.7 (5), p.506-521

2017

Volltextzugriff (PDF)

The role of late/slow replication of the FRA16D in common fragile site induction

Genes chromosomes & cancer, 2004-01, Vol.39 (1), p.71-76

2004

Volltextzugriff (PDF)

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363

2022

Volltextzugriff (PDF)

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4049-4060

2021

Volltextzugriff (PDF)

Tracing the roots of cancer evolution

Cancer discovery, 2014-09, Vol.4 (9), p.995-997

2014

Volltextzugriff (PDF)

CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

Cancer discovery, 2017-01, Vol.7 (1), p.38-53

2017

Volltextzugriff (PDF)

Schedule-dependent synergistic interaction between docetaxel and gefitinib in NSCLC cell lines regardless of the mutation status of EGFR and KRAS and its molecular mechanisms

Journal of cancer research and clinical oncology, 2014-07, Vol.140 (7), p.1087-1095

2014

Volltextzugriff (PDF)

Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL

Leukemia & lymphoma, 2022-10, Vol.63 (12), p.2765-2784

2022

Volltextzugriff (PDF)

Melatonin promotes the proliferation of GC-1 spg cells by inducing metallothionein-2 expression through ERK1/2 signaling pathway activation

Oncotarget, 2017-09, Vol.8 (39), p.65627-65641

2017

Volltextzugriff (PDF)

FHL2 regulates hematopoietic stem cell functions under stress conditions

Leukemia, 2015-03, Vol.29 (3), p.615-624

2015

Volltextzugriff (PDF)

Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes

Neoplasia (New York, N.Y.), 2020-04, Vol.22 (4), p.179-191

2020

Volltextzugriff (PDF)

Predicting Axillary Lymph Node Status With a Nomogram Based on Breast Lesion Ultrasound Features: Performance in N1 Breast Cancer Patients

Frontiers in oncology, 2020-10, Vol.10, p.581321-581321

2020

Volltextzugriff (PDF)

Various detailed characteristics of a new enhanced neurotrophic factor secreting rat derived bone marrow mesenchymal stem cells and its preliminary application in rat models of ischemic stroke

Experimental cell research, 2022-07, Vol.416 (1), p.113140-113140, Article 113140

2022

Volltextzugriff (PDF)

Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death

Molecular medicine reports, 2019-06, Vol.19 (6), p.4863-4871

2019

Volltextzugriff (PDF)

Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior

Frontiers of medicine, 2018-02, Vol.12 (1), p.3-22

2018

Volltextzugriff (PDF)

Left ventricular ejection fraction is associated with intraoperative circulatory collapse during transcatheter aortic valve implantation

Annals of translational medicine, 2021-08, Vol.9 (16), p.1336-1336

2021

Volltextzugriff (PDF)

CARTs for Solid Tumors: Feasible or Infeasible?

Oncology research and treatment, 2017-01, Vol.40 (9), p.540-546

2017

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(17)
Animals
(7)
Mutation
(7)
Female
(5)
Hematology
(5)
Male
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Cancer
(4)
Cell Biology
(4)
Cell Line, Tumor
(4)
Lymphocytes B
(4)
Mice
(4)
Adult
(3)
Aged
(3)
B-Cell Lymphoma
(3)
B-Lymphocytes - Metabolism
(3)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia

Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma

BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells

The role of late/slow replication of the FRA16D in common fragile site induction

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

Tracing the roots of cancer evolution

CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Schedule-dependent synergistic interaction between docetaxel and gefitinib in NSCLC cell lines regardless of the mutation status of EGFR and KRAS and its molecular mechanisms

Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL

Melatonin promotes the proliferation of GC-1 spg cells by inducing metallothionein-2 expression through ERK1/2 signaling pathway activation

FHL2 regulates hematopoietic stem cell functions under stress conditions

Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes

Predicting Axillary Lymph Node Status With a Nomogram Based on Breast Lesion Ultrasound Features: Performance in N1 Breast Cancer Patients

Various detailed characteristics of a new enhanced neurotrophic factor secreting rat derived bone marrow mesenchymal stem cells and its preliminary application in rat models of ischemic stroke

Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death

Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior

Left ventricular ejection fraction is associated with intraoperative circulatory collapse during transcatheter aortic valve implantation

CARTs for Solid Tumors: Feasible or Infeasible?

Aktive Filter

Suchergebnisse filtern